← All stocks

Sight Sciences, Inc.

SGHT No buying or selling
CIK 0001531177 #3178 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

17 insiders · 0 transactions
51.1×

Paul Badawi holds 51.1 times base salary in stock. $33.72M of shares against $659.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul Badawi last reported holding, valued at $5.51, the price Common Stock was last bought or sold at on the open market here, on 6 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Encrantz Staffan
Director
6,521,203
$35.92M
+16.4%
Badawi Paul
President and CEO
6,122,472
$33.72M
+4.5%
Badawi David
Chief Technology Officer
1,982,872
$10.92M
+10.2%
Link Matthew
Chief Commercial Officer
832,293
$4.58M
+11.3%
Bauerlein Alison
Chief Operating Officer
664,709
$3.66M
+65.1%
HAYDEN JEREMY B.
Chief Legal Officer
357,037
$1.97M
+85.9%
Taylor Brenton
EVP, Operations & R&D
264,978
$1.46M
Park Sam Boong
Chief Operating Officer
254,826
$1.40M
−1.3%
Rodberg James
Chief Financial Officer
224,037
$1.23M
+53.4%
Zurbay Donald
Director
193,613
$1.07M
+44.1%
Rashid Kashif
Chief Legal Officer
181,818
$1.00M
Rogers Erica J.
Director
175,352
$965.84K
+21.4%
Raheja Manohar K.
EVP, Research & Development
167,767
$924.06K
Burbach Gerhard F
Director
123,207
$678.62K
+510.5%
Fountain Tamara
Director
109,650
$603.95K
+117.4%
Larsen-Becker Brenda Jane
Director
79,040
$435.35K
+64.4%
Mazzacco Catherine
Director
69,276
$381.57K
+45.7%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 16 Jul 2021